Compound ID | 358
Synonym(s): AS 924 | KY 020 | Cefizox
Class: Beta-lactam (cephalosporin)
Spectrum of activity: | Gram-positive & Gram-negative |
Institute where first reported: | Astellas; Kyoto Pharmaceutical Industries; Asahi Kasei |
Year first mentioned: | 1983 |
Highest developmental phase: | Approved by FDA in 1983 |
Development status: | Discontinued |
Reason Dropped: | Was in pre-registration in Japan later on but seems to have been pulled out. This may be due to side effects (1) |
Chemical structure(s): | |
Canonical SMILES: | C[C@@H](C(=O)NC1=NC(=CS1)/C(=N/OC)/C(=O)N[C@@H]2C(=O)N3C(=CCS[C@H]23)C(=O)OCOC(=O)C(C)(C)C)N |
Isomeric SMILES: | C[C@@H](C(=O)NC1=NC(=CS1)/C(=N/OC)/C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)OCOC(=O)C(C)(C)C)N |
InChI: | InChI=1S/C22H28N6O8S2/c1-10(23)15(29)26-21-24-11(8-38-21)13(27-34-5)16(30)25-14-17(31)28-12(6-7-37-18(14)28)19(32)35-9-36-20(33)22(2,3)4/h6,8,10,14,18H,7,9,23H2,1-5H3,(H,25,30)(H,24,26,29)/b27-13-/t10-,14+,18+/m0/s1 |
InChI Key: | VOPANQNVVCPHQR-IVVGYLHBSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/9578661 |
External links: | |
Guide to Pharmacology: | ceftizoxime alapivoxil |